Clinical results have identified in human, a link between bone mass and mutations in LRP-5 with loss of function causing osteoporosis pseudoglioma syndrome and gain of function leading to pathological thickening of bone [38, 39]. Here, LRP5 is linked to Osteoporosis - pseudoglioma.